Safety and efficacy of flecainide in the treatment of symptomatic children with wolff-parkinson-white syndrome

Pediatric Cardiology

Volumn 31, Issue 8, 2010, Pages 1162-1165

  Núñez, Francisco ^b   Ruiz Granell, Ricardo ^a   Martínez Costa, Cecilia ^a   Morell, Salvador ^a   Brines, Juan ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NONE

Author keywords

Flecainide; Radiofrequency catheter ablation; Supraventricular tachycardia; Wolff Parkinson White syndrome

Indexed keywords

FLECAINIDE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HAIR LOSS; HEART FUNCTION TEST; HEART PALPITATION; HUMAN; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; HUMANS; MALE; TREATMENT OUTCOME; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 78449275118     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9772-z     Document Type: Article

References (24)

1. SM Al-Khatib ELC Pritchett 1999 Clinical features of Wolff-Parkinson- White syndrome Am Heart J 138 403 413 1:STN:280:DyaK1Mzpslyruw%3D%3D 10.1016/S0002-8703(99)70140-7 10467188
2. LD Allan SK Chita GK Sharland D Maxwell K Priestley 1991 Flecainide in the treatment of fetal tachycardias Br Heart J 65 46 48 1:STN:280: DyaK3M7ivVyhsw%3D%3D 10.1136/hrt.65.1.46 1899583
3. A Azancot-Benisty E Jacqz-Aigrain NM Guirgis A Decrepy JF Oury P Blot 1992 Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias J Pediatr 121 608 613 1:STN:280:DyaK3s%2FhvFyrsQ%3D%3D 10.1016/S0022-3476(05) 81156-4 1403399
4. RM Campbell MJ Strieper PA Frias KK Collins GF Van Hare AM Dubin 2003 Survey of current practice of pediatric electrophysiologist for asymptomatic Wolff-Parkinson-White syndrome Pediatrics 111 e245 e247 10.1542/peds.111.3.e245 12612279
5. M Chimienti MT Cullen Jr G Casadei 1995 Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group Eur Heart J 16 1943 1951 1:CAS:528: DyaK28XitlKqsLo%3D 8682031
6. ES Ebenroth TM Cordes RK Darragh 2001 Second-line treatment of fetal supraventricular tachycardia using flecainide acetate Pediatr Cardiol 22 483 487 1:STN:280:DC%2BD387mtVWrsQ%3D%3D 10.1007/s002460010279 11894150
7. M Ferlini AM Colli C Bonanomi L Salvini MA Galli P Salice R Ravaglia M Centola GB Danzi 2009 Flecainide as first-line treatment for supraventricular tachycardia in newborns J Cardiovasc Med 10 372 375 10.2459/JCM.0b013e328329154d
8. FA Fish PC Gillette DW Benson 1991 Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide J Am Coll Cardiol 18 356 365 1:STN:280:DyaK3MzhtV2msg%3D%3D 10.1016/0735-1097(91)90586-X 1906902
9. AC Giardina KH Ehlers MA Engle 1972 Wolff-Parkinson-White syndrome in infants and children: a long-term follow-up study Br Heart J 34 839 846 1:STN:280:DyaE3s%2FgtlWgsQ%3D%3D 10.1136/hrt.34.8.839 5070116
10. JR Hopson AE Buxton RL Rinkenberger K Nademanee JM Heilman MG Kienzle 1996 Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group Am J Cardiol 77 72A 82A 1:STN:280:DyaK287ptVejtw%3D%3D 10.1016/S0002-9149(97)89121-7 8607395
11. Z Ismail M Alwi MK Lim HA Murtazam A Jamaluddin 1994 Treatment with flecainide for symptomatic and refractory tachyarrhythmias in children Acta Paediatr Jpn 36 44 48 1:STN:280:DyaK2c3hvFahsg%3D%3D 8165907
12. BB Lerman CT Basson 2003 High-risk patients with ventricular preexcitation. A pendulum in motion N Engl J Med 349 1787 1789 1:CAS:528:DC%2BD3sXosl2gtb8%3D 10.1056/NEJMp038137 14602876
13. K Niwa N Warita Y Sunami A Shimura S Tateno K Sugita 2004 Prevalence of arrhythmias and conduction disturbances in large population-based simples of children Cardiol Young 14 68 74 10.1017/S104795110400112X 15237674
14. JJ O'Sullivan HM Gardiner C Wren 1995 Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? J Am Coll Cardiol 26 991 994 10.1016/0735-1097(95)00291-9 7560629
15. C Pappone V Santinelli 2005 Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome Circulation 112 2207 2216 16208793
16. C Pappone F Manguso R Santinelli G Vicedomini S Sala G Paglino P Mazzone CC Lang S Gulletta G Augello O Santinelli V Santinelli 2004 Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome N Engl J Med 351 1197 1205 1:CAS:528:DC%2BD2cXns12ku7o%3D 10.1056/NEJMoa040625 15371577
17. JC Perry A Garson 1992 Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety and dosing Am Heart J 124 1614 1621 1:STN:280:DyaK3s%2FpvVWisQ%3D%3D 10.1016/0002-8703(92)90081-6 1462922
18. JF Price NJ Kertesz CS Snyder RA Friedman AL Fenrich 2002 Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age J Am Coll Cardiol 39 517 520 1:CAS:528: DC%2BD38XitFOju7Y%3D 10.1016/S0735-1097(01)01773-9 11823091
19. V Santinelli A Radinovic F Manguso G Vicedomini S Gulletta G Paglino P Mazzone G Ciconte S Sacchi S Sala C Pappone 2009 The natural history of asymptomatic ventricular pre-excitation J Am Coll Cardiol 53 275 280 10.1016/j.jacc.2008.09.037 19147045
20. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412
21. C Timmermans JL Smeets LM Rodriguez G Vrouchos A van den Dool HJ Wellens 1995 Aborted sudden death in the Wolff-Parkinson-White syndrome Am J Cardiol 76 492 494 1:STN:280:DyaK2MzotF2ktA%3D%3D 10.1016/S0002-9149(99)80136-2 7653450
22. DM Todd GJ Klein AD Krahn AC Skanes R Yee 2003 Asymptomatic Wolff-Parkinson-White syndrome: is it time to revisit guidelines? J Am Coll Cardiol 41 245 248 10.1016/S0735-1097(02)02707-9 12535817
23. G Vignati E Balla L Mauri M Lunati A Figini 2000 Clinical and electrophysiologic evolution of the Wolff-Parkinson-White syndrome in children: impact on approaches to management Cardiol Young 10 367 375 1:STN:280: DC%2BD3M%2FmtVCnug%3D%3D 10.1017/S1047951100009677 10950334
24. HJ Wellens 2005 When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram Circulation 112 2201 2207 10.1161/CIRCULATIONAHA.104.483321 16203931